ACER THERAPEUTICS INC (ACER)

US00444P1084 - Common Stock

0.9  +0.03 (+3.41%)

After market: 0.8005 -0.1 (-11.06%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
0.001.26M0.000.000.00
Operating Expenses
24.61M17.21M22.80M29.90M21.71M
Research and Development
11.92M6.51M11.85M13.85M12.45M
Selling, General, and Administrative Expenses
12.69M10.70M10.95M16.05M9.26M
Operating Income
-24.61M-15.95M-22.80M-29.90M-21.71M
Interest Income/Expense
-1.50M-25.60K-80.00K480.00K430.00K
Other Income/Expense
-1.72MN/AN/AN/AN/A
Non Recurring Items
1.60M600.00KN/AN/AN/A
Income Before Taxes
-26.24M-15.37M-22.89M-29.42M-21.28M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-26.24M-15.37M-22.89M-29.42M-21.28M
EBITDA
-24.55M-15.88M-22.73M-29.84M-21.68M
 
Per Share Data
EPS Diluted Total Ops
-1.66-1.08-2.06-2.91-2.49
Non GAAP EPS
-1.66-0.88-2.06-2.91-2.45
 
Statistics
Profit Margin
N/A-1220.16%N/AN/AN/A
Operating Profit Margin
N/A-1265.75%N/AN/AN/A

All data in USD

Charts